Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,218,135 | 1,355,802 | 1,443,385 | 1,506,310 | 1,335,690 |
| Marketable Securities | 400,000 | 625,000 | 375,000 | 120,000 | 250,000 |
| Receivables | 723,639 | 698,037 | 707,095 | 705,794 | 627,841 |
| Inventories | 539,302 | 542,555 | 577,321 | 597,039 | 611,827 |
| Other current assets | 354,215 | 325,851 | 314,535 | 320,809 | 310,404 |
| TOTAL | $4,390,423 | $3,681,666 | $3,539,898 | $3,435,428 | $3,245,752 |
| Non-Current Assets | |||||
| PPE Net | 176,422 | 169,281 | 166,236 | 169,646 | 222,476 |
| Intangibles | 6,948,863 | 6,815,393 | 6,974,991 | 7,171,169 | 7,123,180 |
| Other Non-Current Assets | 740,007 | 695,528 | 645,950 | 617,116 | 612,657 |
| TOTAL | $7,865,292 | $7,680,202 | $7,787,177 | $7,957,931 | $7,958,313 |
| Total Assets | $12,255,720 | $11,361,870 | $11,327,080 | $11,393,360 | $11,204,070 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 31,000 | 605,798 | 605,375 | 604,954 | 604,507 |
| Accounts payable and accrued liabilities | 85,425 | 97,096 | 80,976 | 102,750 | 109,850 |
| Accrued Expenses | 858,578 | 800,993 | 826,530 | 793,914 | 769,942 |
| TOTAL | $1,029,977 | $1,556,025 | $1,562,206 | $1,536,692 | $1,573,329 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,080,802 | 5,100,983 | 5,105,111 | 5,107,988 | 5,110,757 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 4 |
| Other Non-Current Liabilities | 182,086 | 167,033 | 153,583 | 163,976 | 189,372 |
| TOTAL | $7,054,672 | $6,043,244 | $6,068,408 | $6,119,670 | $6,141,363 |
| Total Liabilities | $8,084,649 | $7,599,269 | $7,630,614 | $7,656,362 | $7,714,692 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,455 | 61,754 | 63,040 | 62,345 | 62,957 |
| Common Shares | 61 | 61 | 61 | 61 | 61 |
| Retained earnings | 936,705 | 871,651 | 864,511 | 879,129 | 884,771 |
| Other shareholders' equity | -603,397 | -888,227 | -882,394 | -842,147 | -1,035,399 |
| TOTAL | $4,171,067 | $3,762,599 | $3,696,461 | $3,736,997 | $3,489,373 |
| Total Liabilities And Equity | $12,255,716 | $11,361,868 | $11,327,075 | $11,393,359 | $11,204,065 |